Option Care Health (OPCH)
(Real Time Quote from BATS)
$27.25 USD
+0.27 (1.00%)
Updated Jul 10, 2024 01:28 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPCH 27.25 +0.27(1.00%)
Will OPCH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OPCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPCH
Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol
3 Stocks Backed by High Efficiency to Boost Portfolio Returns
OPCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for June 10th
Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon
Option Care (OPCH) Upgraded to Strong Buy: Here's Why
Other News for OPCH
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
The 3 Highest-Rated Medical Stocks You Can Buy Today
3 Stocks Backed by High Efficiency To Boost Portfolio Returns
Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Gilead Sciences (GILD)
Option Care Health: A Deep Dive Into Its Market Dominance